Business Context and Reporting Period
This Form 8-K filing by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) reports on the Annual Meeting of Stockholders held on June 6, 2019. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol RMED.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
The filing details the outcomes of two matters submitted to a vote of security holders:
- Shareholder Participation: Of 12,836,970 shares outstanding as of April 10, 2019, 11,058,067 shares (approximately 86%) were represented at the meeting.
- Election of Directors:
- Dean Irwin: Re-elected with 8,042,173 votes "For" and 1,259,280 "Withheld".
- Mark Saad: Re-elected with 2,314,954 votes "For" and 6,986,499 "Withheld".
- Ratification of Auditors: The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019, was ratified with 10,999,582 votes "For", 8,708 "Against", and 49,777 "Abstain".
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the significant number of votes "Withheld" for director Mark Saad (6,986,499) compared to Dean Irwin.
- Confirm the company name is Ra Medical Systems, Inc., as the input metadata referenced "Catheter Precision, Inc."
- Review subsequent filings for financial performance data, as this 8-K contains no financial metrics.